Balart has their stories in this week’s good news wrap-up.

Jiahui International Cancer Center (JICC) has stabilized a U.S. patient with advanced non-small cell lung cancer (NSCLC) and Parkinson's disease using ivonescimab, a novel immunotherapy currently ...